ArticleFrontiers in immunology2021
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic.
Priyanka Shah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
86 papers cite itlatest 60 shown
this paperpooled itcites it